Evolve Today’s Biopharma Focus for Tomorrow’s Better World

In this webinar, Dr. John Gebler [Phenomenex] will give an overview of current analytical solutions for the rapidly evolving biopharma market. Additional information will include providing key areas of opportunities in the future and how the industry can work together to provide LC and sample preparation solutions for the emerging biopharma challenges.

Register Free: https://www.chromatographyonline.com/lcgc_w/biopharma

Event Overview:

This webinar will cover the evolution and impact of novel biologic modalities and catalysts of solutions to address today’s traditional and emerging biopharma challenges. This includes a review of the past few years of biopharma mainstream success and how it has positioned this industry to gain global focus in a short period of time. This presentation will discuss current analytical biopharma solutions and how new, innovative efforts have recently progressed to advance biologics today and tomorrow.

Key Learning Objectives:

• Understand the importance of advancing biotherapeutics
• Learn about the Phenomenex current portfolio for traditional and emerging biologic modalities
• Identify future products opportunities, focusing on emerging modalities such as adeno-associated viruses and mRNA
• Learn about the new collaborations with biopharma thought leaders through a new laboratory, Phenomenex Innovation Center

Who Should Attend:

• Bench/lead scientists, managers, directors of analytical development and process development
• Anyone in a biopharma company wanting to learn about new technologies and solutions

Speaker:

John Gebler, Ph.D.
Director of Strategic Biopharmaceutical Business Development
Phenomenex

Dr. John Gebler is currently Director of Strategic Biopharmaceutical Business Development for Phenomenex. He has been with the company since 2021 working with Phenomenex and Danaher leadership to create and manage a biopharma separation and sample prep consumables growth vision. Dr. Gebler also manages the execution of a biopharma roadmap with Phenomenex innovation, marketing, and sales partners. He earned his Ph.D. from the University of Utah studying mechanistic aspects of prenyl transferases. In Dr. Gebler's spare time, he enjoys time with family, hiking, biking, camping, and traveling.

Register Free: https://www.chromatographyonline.com/lcgc_w/biopharma